About Plexxikon
Plexxikon is a company based in Berkeley (United States) founded in 2000 was acquired by Daiichi Sankyo in February 2011.. Plexxikon has raised $72.86 million across 2 funding rounds from investors including Daiichi Sankyo, Gimv and Pappas Capital. Plexxikon offers products and services including Zelboraf and Turalio. Plexxikon operates in a competitive market with competitors including Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others.
- Headquarter Berkeley, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Plexxikon Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$72.86 M (USD)
in 2 rounds
-
Latest Funding Round
$46 M (USD), Series B
May 26, 2004
-
Investors
Daiichi Sankyo
& 7 more
-
Employee Count
Employee Count
-
Acquired by
Daiichi Sankyo
(Feb 28, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Plexxikon
Plexxikon offers a comprehensive portfolio of products and services, including Zelboraf and Turalio. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A drug invented for personalized medicine treatments.
Another drug developed for personalized medicines.
Unlock access to complete
Leadership Team
1 people
Secretary Team
1 people
Assistant Team
1 people
Treasurer Team
1 people
Unlock access to complete
Funding Insights of Plexxikon
Plexxikon has successfully raised a total of $72.86M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $46 million completed in May 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $46.0M
-
First Round
First Round
(25 Apr 2002)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2004 | Amount | Series B - Plexxikon | Valuation |
investors |
|
| Apr, 2002 | Amount | Series A - Plexxikon | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Plexxikon
Plexxikon has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include Daiichi Sankyo, Gimv and Pappas Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm focusing on life science sector
|
Founded Year | Domain | Location | |
|
VC firm making investment in early stage startups in the US
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on healthcare companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Plexxikon
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Plexxikon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Plexxikon Comparisons
Competitors of Plexxikon
Plexxikon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
|
| domain | founded_year | HQ Location |
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Plexxikon
Frequently Asked Questions about Plexxikon
When was Plexxikon founded?
Plexxikon was founded in 2000 and raised its 1st funding round 2 years after it was founded.
Where is Plexxikon located?
Plexxikon is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Is Plexxikon a funded company?
Plexxikon is a funded company, having raised a total of $72.86M across 2 funding rounds to date. The company's 1st funding round was a Series A of $26.86M, raised on Apr 25, 2002.
What does Plexxikon do?
Founded in 2000 in Berkeley, United States, Plexxikon operates in the pharmaceutical sector, focusing on small molecule drugs for oncology, central nervous system disorders, and autoimmune conditions. A proprietary Scaffold-Based Drug Discovery Platform is utilized to create selective therapies. ZELBORAF (vemurafenib), discovered in 2005, was co-developed with Roche and approved in over 40 countries, accompanied by a diagnostic tool. The company was acquired by Daiichi Sankyo in 2011.
Who are the top competitors of Plexxikon?
Plexxikon's top competitors include Merck, Roivant Sciences and Amgen.
What products or services does Plexxikon offer?
Plexxikon offers Zelboraf and Turalio.
Who are Plexxikon's investors?
Plexxikon has 8 investors. Key investors include Daiichi Sankyo, Gimv, Pappas Capital, Advanced Technology Ventures, and Alta Partners.